ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1793

Goblet Cell Specific Anti-Apoptotic Role of Interleukin-24 in Spondyloarthritis-Associated Ileitis

Amy Cameron1, Rabina Giri2, Jakob Begun2, Timothy Wells1, Ranjeny Thomas3 and Anne-Sophie Bergot1, 1Frazer Institute, The University of Queensland, Woolloongabba, Australia, 2Mater Research Institute-UQ, Woolloongabba, Australia, 3Frazer Institute, The University of Queensland, Brisbane, Australia

Meeting: ACR Convergence 2023

Keywords: Apoptosis, cytokines, Inflammation, Mouse Models, Other, spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1776–1795) Spondyloarthritis Including Psoriatic Arthritis – Basic Science Poster

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: The loss of intestinal barrier integrity is a key contributor to gut inflammation, however the mechanism behind this dysregulation is not well understood. The ZAP-70W163C BALB/c (SKG) mouse model of Spondyloarthritis (SpA) develops IL-23-dependent Crohn’s-like ileitis after systemic curdlan administration, with fecal dysbiosis, ileal goblet cell depletion and ER stress. IL-24 is associated with ER stress and apoptosis and increased levels were observed in inflammatory bowel disease (IBD) and SpA. To help elucidate the mechanism behind intestinal barrier dysfunction and goblet cell depletion in IBD, we assessed the role of IL-24 in ileal ER stress-mediated apoptosis in SKG mice.

Methods: SKG and control BALB/c ileum was analysed by histology and immunofluorescence (IF). Ileal epithelial cells were analysed by flow cytometry. ER stress was induced with thapsigargin in the MUC2hi human colonic epithelial cell line LS174T in the presence of IL-24 or control siRNA. Gene expression was analysed by RT-qPCR and protein by flow cytometry.

Results: Naïve SKG ileum has fecal dysbiosis. In SKG ileum, expression of Il24 and ER stress marker transcripts were increased relative to BALB/c ileum. By IF, IL-24 localised to the ileal goblet cells. UEA-1 expression in Ep-CAM+ intestinal epithelial cells was significantly increased, indicating increased mucin production in SKG mice compared to BALB/c. IL-24 knockdown in LS174T epithelial cells in vitro increased ER stress and apoptosis including increased CHOP, DR5 and active caspase-3 expression.

Conclusion: IL-24, a goblet cell-specific cytokine in small intestine mitigates ER stress-induced apoptosis in mucin-producing epithelial cells. This suggests that ER stress-associated IL-24 in SKG ileum is insufficient to prevent the cascade to IBD that commences with goblet cell apoptosis and epithelial barrier breakdown.


Disclosures: A. Cameron: None; R. Giri: None; J. Begun: None; T. Wells: None; R. Thomas: CSL, 2, 5, Janssen-Cilag, 6, Sandoz, 6; A. Bergot: None.

To cite this abstract in AMA style:

Cameron A, Giri R, Begun J, Wells T, Thomas R, Bergot A. Goblet Cell Specific Anti-Apoptotic Role of Interleukin-24 in Spondyloarthritis-Associated Ileitis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/goblet-cell-specific-anti-apoptotic-role-of-interleukin-24-in-spondyloarthritis-associated-ileitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/goblet-cell-specific-anti-apoptotic-role-of-interleukin-24-in-spondyloarthritis-associated-ileitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology